|

Future Optimal Research and Care Evaluation - Aortic Stenosis

RECRUITINGSponsored by St. Antonius Hospital
Actively Recruiting
SponsorSt. Antonius Hospital
Started2023-11-27
Est. completion2027-08-01
Eligibility
Age18 Years – 110 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06168123

Summary

In the past decade the treatment of aortic valve stenosis has rapidly changed. At first, transcatheter aortic valve implantation (TAVI) was a last resort option for inoperable patients. Nowadays, it more and more becomes an alternative to surgical aortic valve replacement (SAVR) - also in younger and lower risk patients. This poses important questions to clinical practise regarding the optimal life-time management of each individual patient. Which involves (durability of) treatment modality (surgical vs. transcatheter vs. conservative treatment) as well as the duration and type of the required antithrombotic treatment. Objective: to evaluate the effect of treatment modality (surgical vs. transcatheter vs. conservative treatment) and its complications on quality of life and survival in AoS patients.

Eligibility

Age: 18 Years – 110 YearsHealthy volunteers accepted
Inclusion Criteria:

* Older than 18 years of age
* Severe or moderate aortic stenosis

No exclusion criteria are applicable to this registry

Conditions3

Heart DiseaseModerate Aortic Valve StenosisSevere Aortic Valve Stenosis

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.